DOSSIER · UPDATED 18 JUN 2026

Sagimet Biosciences

Sagimet Biosciences Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases such as non-alcoholic steatohepatitis (NASH),…

sagimet.com ↗Claim this profile

Founded: 2007
Headcount: 34
Open roles: 0
Last raised: Post Ipo Equity · $175M

SECTION I · THE BRIEF

Inside Sagimet Biosciences

Brief #92230Updated 18 JUN 2026SAN MATEOKLEINER PERKINSPOST IPO EQUITY

Employbl Dossier

Sagimet Biosciences

Founded: 2007
Headcount: 34
Open roles: 0
Last raised: Post Ipo Equity · $175M

Section II · Premium ProfileMembers only

01Engineering interview process at Sagimet BiosciencesLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Sagimet Biosciences brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Lucas Pelkmans

OPEN ROLES

Hiring at Sagimet Biosciences

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $581,156,608